News & Blog

Still the Elite!

Need your questions asked? Our IHC expert Liz can help!

Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells

Cellecta’s CloneTracker XP™ was recently used in a study on oestrogen receptor-positive breast cancer relapse even after treatment with endocrine therapies (ET).

Partnerships That Just...Click!

2BScientific invests into Cellexus International Limited

2BScientific Limited today announces their investment into Cellexus International Limited.

Lightning fast labelling with oYo from Alpha Thera

De-mystifying Proximity ligation assays

Discover 2BFound

Seamless Solutions, Swift Results with 2BFound - Your Gateway to Essential Research Reagents.

Interview with L'Espresso

Harvesting Honey in the Afram Plains

Uplifting beekeeping training capacity in Nilgiris

2B The Difference - What separates 2BScientific from the competition?

Bees for Development - Conservation in Malawi and Ethiopia!